66 results
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
Scientific, where, from 2016–2020, she served as Vice President, Strategy and Innovation for the clinical supply chain business. In this role, she … led strategic planning, developed customer-facing innovation programs, and drove the business case for the company’s multi-billion acquisition
8-K
EX-99.1
RGEN
Repligen Corp.
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
. Loeillot said, “I am excited to join Repligen, which has quickly become the innovation leader in bioprocessing. I look forward to applying my commercial
8-K
EX-99.1
2l05hboxpzcdbes bo
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.1
z1br4mgxakifbwp
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
EX-99.1
c98oojn
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
424B7
7571vq
5 Nov 21
Prospectus with selling stockholder info
4:16pm
8-K
EX-99.1
ck66l2s
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
8-K
EX-99.2
pnkkcpls7r hp0c4iguu
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am